This was posted on the IMM threads a little while back by Dr Daniel Tillett ,who has a phd in molecular genetics and bio chemistry and who is also CEO of Aussie Bio company Race oncology.
“Translation: Trial was too small to see statistical differences even if there was a real clinical effect. Efti worked so well in the cold tumours (i.e. the ones where Keytruda does nothing) that they think the FDA is going to be very impressed.I tripled my IMM holding today. I think the Cohort B results are very impressive.”
This was posted on the IMM threads a little while back by Dr...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.005(1.27%) |
Mkt cap ! $581.0M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 41.0¢ | 38.5¢ | $1.351M | 3.389M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 16911 | 40.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.5¢ | 154170 | 1 |
View Market Depth
| Last trade - 16.10pm 03/09/2024 (20 minute delay) ? |
| IMM (ASX) Chart |